Literature DB >> 26421789

Prognostic Factors after Liver Resection for Colorectal Liver Metastasis.

Margarida Matias1, Mafalda Casa-Nova1, Mariana Faria1, Ricardo Pires2, Joana Tato-Costa2, Leonor Ribeiro1, Luís Costa1.   

Abstract

INTRODUCTION: Surgery is the only potentially curative treatment for patients with colorectal liver metastases, resulting in 5-year survival rates of 36 -€“ 58. Although many studies have been performed to determine prognostic factors for tumor recurrence and survival after resection of colorectal liver metastases, there are few prognostic scoring systems stratifying patients undergoing surgery for colorectal liver metastases into risk group models.
OBJECTIVES: To identify, evaluate and compare the existing prognostic scores for survival after surgery for resection of colorectal liver metastases.
MATERIAL AND METHODS: Electronic search in PubMed, Cochrane and Embase from 1990 to 2013 using the terms '€˜hepatic resection', '€˜colorectal cancer'€™, 'liver metastasis', '€˜hepatectomy', '€˜prognostic'€™, and '€˜score'€˜. Only studies proposing a prognostic model or risk stratification based on clinical and/or pathological variables were included.
RESULTS: From 1996 to June 2013, 19 scoring systems were identified, including one nomogram. Thirty prognostic factors were identified although none of the factors was common to all prognostic models. The 4 factors most often included were: number of liver metastases, regional lymph node metastization of primary tumor, preoperative CEA level and maximum size of metastases. The median study sample size was 305 patients (81-1 568 patients) and median follow-up was 33 months (16-54 months). All studies were retrospective and used the Cox proportional hazards model for multi-variable analysis.
CONCLUSION: Several factors have been constantly reported as having prognostic value after liver resection of colorectal livermetastases, although there is no consensus on the ideal scoring system.

Entities:  

Mesh:

Year:  2015        PMID: 26421789     DOI: 10.20344/amp.4816

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  8 in total

1.  FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.

Authors:  Akira Watanabe; Norifumi Harimoto; Takehiko Yokobori; Kenichiro Araki; Norio Kubo; Takamichi Igarashi; Mariko Tsukagoshi; Norihiro Ishii; Takahiro Yamanaka; Tadashi Handa; Tetsunari Oyama; Tetsuya Higuchi; Ken Shirabe
Journal:  Int J Clin Oncol       Date:  2019-10-14       Impact factor: 3.402

2.  Carcinoembryonic antigen reduction after medical treatment in patients with metastatic colorectal cancer: a systematic review and meta-analysis.

Authors:  Giuseppe Antonio Colloca; Antonella Venturino; Domenico Guarneri
Journal:  Int J Colorectal Dis       Date:  2019-01-22       Impact factor: 2.571

3.  mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy.

Authors:  E P van der Stok; M Smid; A M Sieuwerts; P B Vermeulen; S Sleijfer; N Ayez; D J Grünhagen; J W M Martens; C Verhoef
Journal:  Mol Oncol       Date:  2016-09-20       Impact factor: 6.603

4.  Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation.

Authors:  Yijiao Chen; Wenju Chang; Li Ren; Jingwen Chen; Wentao Tang; Tianyu Liu; Mi Jian; Yu Liu; Ye Wei; Jianmin Xu
Journal:  Oncologist       Date:  2020-03-17

5.  A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases.

Authors:  Yuma Wada; Mitsuo Shimada; Yuji Morine; Tetsuya Ikemoto; Yu Saito; Hideo Baba; Masaki Mori; Ajay Goel
Journal:  Eur J Cancer       Date:  2022-01-14       Impact factor: 9.162

6.  Short- and long-term outcomes of laparoscopic hepatectomy for colorectal liver metastases in elderly patients.

Authors:  Meng Yue; Shiquan Li; Guoqiang Yan; Chenyao Li; Zhenhua Kang
Journal:  Cancer Manag Res       Date:  2018-08-10       Impact factor: 3.989

7.  A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.

Authors:  Jie-Ying Liang; Hao-Cheng Lin; Jingwen Liu; De-Shen Wang; Yun-Fei Yuan; Bin-Kui Li; Yun Zheng; Xiao-Jun Wu; Gong Chen; Feng-Hua Wang; Zhi-Qiang Wang; Zhi-Zhong Pan; De-Sen Wan; Rui-Hua Xu; Yu-Hong Li
Journal:  Cancer Med       Date:  2021-02-04       Impact factor: 4.452

8.  Prognostic Nomogram for Liver Metastatic Colon Cancer Based on Histological Type, Tumor Differentiation, and Tumor Deposit: A TRIPOD Compliant Large-Scale Survival Study.

Authors:  Le Kuai; Ying Zhang; Ying Luo; Wei Li; Xiao-Dong Li; Hui-Ping Zhang; Tai-Yi Liu; Shuang-Yi Yin; Bin Li
Journal:  Front Oncol       Date:  2021-10-12       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.